Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Customising Cancer Treatment - The Challenge Of Genetics

22.12.2004


At the Norwegian Radium Hospital in Oslo, scientists are approaching methods that will improve the patients’ chances of survival and reduce unnecessary treatment.

The cancer treatment of today involves a lot of trial and error. Cancer cells that have started to grow uncontrollably, must be stopped. We use different kinds of medicinal drugs to stop cell growth and induce apoptosis, i.e. make the cells commit suicide. However, nobody knows whether or not the chosen form of medication has an effect on the patient until it has been tried out over a period of time. There is always a risk of losing time, especially if the tumour is big and has to be treated with medication before it is possible to perform surgery.

The problem with cancer treatment today is that it does not consider the genetic variety of human beings and the fact that each individual tumour is genetically unique.



"By giving the same medication to all patients that have the same diagnosis, there is a risk that some may die in the course of the disease because the drug is not working, while others may be poisoned by excessive doses. Although most patients will recover, it is not easy to predict who will recover and who will not," says Vessela Nedelcheva Kristensen.

By conducting meticulous research and with the help of the latest, state-of-the-art instrument called Nanochip Workstation, Nedelcheva Kristensen and her research team are trying to identify the genes that have an influence on how anti-cancer drugs work on each patient. With grants from the Research Council of Norway’s National Programme for Research in Functional Genomics, FUGE, this young scientist takes part in research that may revolutionise cancer treatment. The researchers take samples from each tumour and analyse them, and they take blood samples from the patients to analyse their genetic sensitivity to an anti-cancer drug. This sensitivity varies according to each individual.

"By genetically testing each tumour, we may be able to say which form of treatment suits each patient. This is groundwork for individually tailored cancer treatment," she says.

By conducting meticulous research and with the help of the latest, state-of-the-art instrument called Nanochip Workstation, Nedelcheva Kristensen and her research team are trying to identify the genes that have an influence on how anti-cancer drugs work on each patient. With grants from the Research Council of Norway’s National Programme for Research in Functional Genomics, FUGE, this young scientist takes part in research that may revolutionise cancer treatment. The researchers take samples from each tumour and analyse them, and they take blood samples from the patients to analyse their genetic sensitivity to an anti-cancer drug. This sensitivity varies according to each individual.

"By genetically testing each tumour, we may be able to say which form of treatment suits each patient. This is groundwork for individually tailored cancer treatment," she says.

Thomas Evensen | alfa
Further information:
http://www.forskningsradet.no/forport/application?lang=en_UK

More articles from Health and Medicine:

nachricht Improving memory with magnets
28.03.2017 | McGill University

nachricht Graphene-based neural probes probe brain activity in high resolution
28.03.2017 | Graphene Flagship

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Transport of molecular motors into cilia

28.03.2017 | Life Sciences

A novel hybrid UAV that may change the way people operate drones

28.03.2017 | Information Technology

NASA spacecraft investigate clues in radiation belts

28.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>